| Literature DB >> 35295265 |
Dongfeng Zhang1, Haoran Xing1, Rui Wang2, Jinfan Tian1, Zhiguo Ju3, Lijun Zhang4, Hui Chen5, Yi He2, Xiantao Song1.
Abstract
Aims: Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is characterized by a low success rate and an increase in complications. This study aimed to explore a new and simple classification method based on plaque composition to predict guidewire (GW) crossing within 30 min of CTO lesions.Entities:
Keywords: chronic total occlusion; computed tomographic angiography; coronary artery disease; percutaneous coronary intervention; plaque composition
Year: 2022 PMID: 35295265 PMCID: PMC8920558 DOI: 10.3389/fcvm.2022.762351
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
Figure 1Chronic total occlusion (CTO) classification system.
Baseline clinical characteristics.
|
|
|
|
| |
|---|---|---|---|---|
| Age, years | 58.7 ± 10.7 | 57.5 ± 12.1 | 59.0 ± 10.3 | 0.295 |
| Male, | 176 (85.0) | 39 (92.9) | 137 (83.0) | 0.111 |
| BMI, kg/m2 | 26.3 ± 3.3 | 26.5 ± 3.5 | 26.3 ± 3.3 | 0.759 |
| Smoking history, | 112 (54.1) | 24 (57.1) | 88 (53.3) | 0.658 |
| Hypertension, | 131 (63.3) | 24 (57.1) | 107 (64.8) | 0.355 |
| Diabetes, | 62 (30.0) | 13 (31.0) | 49 (29.7) | 0.874 |
| Hyperlipidemia, | 82 (39.6) | 14 (33.3) | 68 (41.2) | 0.351 |
| Previous MI, | 53 (25.6) | 12 (28.6) | 41 (24.8) | 0.622 |
| Previous PCI, | 39 (18.8) | 6 (14.3) | 33 (20.0) | 0.398 |
| Previous CABG, | 2 (1.0) | 0 (0) | 2 (1.2) | 1.000 |
| Prior stroke, | 19 (9.2) | 5 (11.9) | 14 (8.5) | 0.699 |
| Renal disease, | 13 (6.3) | 2 (4.8) | 11 (6.7) | 0.922 |
| PVD, | 10 (4.8) | 2 (4.8) | 8 (4.8) | 1.000 |
| LVEF (%) | 61.7 ± 8.3 | 61.0 ± 5.8 | 61.8 ± 8.8 | 0.113 |
| eGFR, mL/min/1.73 m2 | 94.1 ± 16.1 | 92.8 ± 19.6 | 94.4 ± 15.2 | 0.987 |
| TG, mmol/L | 1.8 ± 1.0 | 1.7 ± 0.9 | 1.8 ± 1.0 | 0.692 |
| TC, mmol/L | 3.9 ± 1.0 | 3.7 ± 1.0 | 3.9 ± 0.9 | 0.205 |
| LDL, mmol/L | 2.3 ± 0.8 | 2.1 ± 0.8 | 2.3 ± 0.8 | 0.312 |
| HDL, mmol/L | 1.0 ± 0.2 | 1.0 ± 0.2 | 1.0 ± 0.2 | 0.126 |
| FBG, mmol/L | 6.6 ± 2.3 | 6.5 ± 2.3 | 6.6 ± 2.3 | 0.393 |
| HbA1c (%) | 6.4 ± 1.1 | 6.4 ± 1.1 | 6.4 ± 1.1 | 0.487 |
| Occlusion time ≥ 12 months or unknown, | 137 (66.2) | 31 (73.8) | 106 (64.2) | 0.242 |
| Reattempt of failed CTO PCI, | 28 (13.5) | 4 (9.5) | 24 (14.5) | 0.396 |
CTO, chronic total occlusion; BMI, body mass index; MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; PVD, peripheral vascular disease; LVEF, left ventricular ejection fraction; eGFR, estimated glomerular filtration rate; TG, triglyceride; TC, total cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; FBG, fasting blood glucose.
Angiographic and procedural characteristics.
|
|
|
|
| |
|---|---|---|---|---|
|
| ||||
| Target vessel | 0.177 | |||
| LM, | 2 (1.0) | 0 (0) | 2 (1.2) | |
| LAD, | 85 (41.1) | 12 (28.6) | 73 (44.2) | |
| LCX, | 22 (10.6) | 7 (16.7) | 15 (9.1) | |
| RCA, | 98 (47.3) | 23 (54.8) | 75 (45.5) | |
| Multiple occlusion, | 9 (4.3) | 2 (4.8) | 7 (4.2) | 1.000 |
| Ostial location, | 10 (4.8) | 1 (2.4) | 9 (5.5) | 0.670 |
| Blunt stump at entry, | 76 (36.7) | 12 (28.6) | 64 (38.8) | 0.220 |
| Side branch at entry, | 90 (43.5) | 14 (33.3) | 76 (46.1) | 0.137 |
| Bending > 45°, n (%) | 48 (23.2) | 11 (26.2) | 37 (22.4) | 0.606 |
| Calcium, any, | 45 (21.7) | 2 (4.8) | 43 (26.1) | 0.003 |
| Heavy calcium, | 20 (9.7) | 0 (0) | 20 (12.1) | 0.037 |
| Occlusion length ≥ 20 mm, | 85 (41.1) | 16 (38.1) | 69 (41.8) | 0.661 |
| Bridging collaterals, | 21 (10.1) | 5 (11.9) | 16 (9.7) | 0.891 |
| Retrograde collaterals grade ≥ 2, | 195 (94.2) | 37 (88.1) | 158 (95.8) | 0.127 |
| Severe proximal vessel disease, | 68 (32.9) | 16 (38.1) | 52 (31.5) | 0.418 |
| Severe distal vessel disease, | 86 (41.5) | 16 (38.1) | 70 (42.4) | 0.611 |
|
| ||||
| Radial access, | 85 (41.3) | 17 (40.5) | 68 (41.5) | 0.908 |
| Guiding catheter | 0.609 | |||
| 6-F, | 136 (65.7) | 29 (69.0) | 107 (64.8) | |
| 7-F, | 71 (34.3) | 13 (31.0) | 58 (35.2) | |
| Retrograde injection, | 97 (46.9) | 18 (42.9) | 79 (47.9) | 0.560 |
| Retrograde wiring approach, | 19 (9.2) | 0 (0) | 19 (11.5) | 0.045 |
| Over-the-wire balloon support, | 10 (4.8) | 0 (0) | 10 (6.1) | 0.218 |
| Simultaneous PCI for non-CTO lesion, | 73 (35.3) | 17 (40.5) | 56 (33.9) | 0.429 |
| Mean number of wires, | 3.6 ± 1.8 | 3.0 ± 1.2 | 3.8 ± 2.0 | 0.016 |
| Successful GW crossing within 30, | 131 (63.3) | 36 (85.7) | 95 (57.6) | 0.001 |
| Final successful GW crossing, | 161 (77.8) | 40 (95.2) | 121 (73.3) | 0.002 |
| Successful implantation of stent, | 152 (73.4) | 36 (85.7) | 116 (70.3) | 0.044 |
| Dissection or perforation, | 9 (4.2) | 2 (4.8) | 7 (4.2) | 1.000 |
CTO, chronic total occlusion; LM, left main; LAD, left anterior descending; LCX, left circumflex; RCA, right coronary artery; PCI, percutaneous coronary intervention; GW, guidewire.
Figure 2Kaplan–Meier curves of successful 30 min (left) and final (right) guidewire (GW) crossing in patients with soft and hard CTO.
Figure 3Two representative cases showing plaque compositions and guidewire (GW) crossing outcomes. Lesion (A) was a right coronary artery (RCA) lesion with soft CTO (80.7% necrotic core, 17.4% fibrous fatty, 1.6% fibrous, and 0% dense calcium) and the GW was successfully passed at 20 min. Lesion (B) was a left anterior descending artery (LAD) lesion with hard CTO (46.4% fibrous, 21.9% dense calcium, 17.8% fibrous fatty, and 13.5% necrotic core) and the GW was failed to be advanced cross the CTO.
Computed tomographic characteristics.
|
|
|
|
| |
|---|---|---|---|---|
| Occlusion length, mm | 20.3 ± 15.8 | 16.3 ± 10.4 | 21.3 ± 16.8 | 0.066 |
| Occlusion length ≥ 15 mm, | 107 (51.7) | 21 (50.0) | 86 (52.1) | 0.806 |
| Occlusion length ≥ 20 mm, | 80 (38.6) | 12 (28.6) | 68 (41.2) | 0.133 |
| Multiple occlusion, | 10 (4.8) | 1 (2.4) | 9 (5.5) | 0.670 |
| Proximal reference vessel diameter, mm | 3.0 ± 0.7 | 2.8 ± 0.7 | 3.0 ± 0.7 | 0.013 |
| Distal reference vessel diameter, mm | 2.2 ± 0.5 | 2.2 ± 0.5 | 2.2 ± 0.5 | 0.755 |
| Blunt stump, | 74 (35.7) | 9 (21.4) | 65 (39.4) | 0.030 |
| Side branch, | 65 (31.4) | 6 (14.3) | 59 (35.8) | 0.007 |
| Bending > 45°, | 42 (20.3) | 9 (21.4) | 33 (20.0) | 0.837 |
| Calcium, any, | 80 (38.6) | 0 (0) | 80 (48.5) | <0.001 |
| Calcium ≥ 50% CSA, | 63 (30.4) | 0 (0) | 63 (38.2) | <0.001 |
CTO, chronic total occlusion; CSA, cross-sectional area.
Predictive assessment of different scoring systems.
|
|
|
|
| |
|---|---|---|---|---|
| J-CTO | 1.4 ± 1.1 | 1.1 ± 1.0 | 1.4 ± 1.1 | 0.057 |
| PROGRESS-CTO | 1.2 ± 0.8 | 1.1 ± 0.8 | 1.2 ± 0.8 | 0.671 |
| CT-RECTOR | 1.7 ± 1.2 | 1.2 ± 0.9 | 1.8 ± 1.2 | 0.002 |
| KCCT | 2.4 ± 1.8 | 1.9 ± 1.1 | 2.5 ± 1.9 | 0.162 |
| CTA-J CTO | 1.5 ± 1.3 | 0.8 ± 0.9 | 1.6 ± 1.3 | <0.001 |
Figure 4Receiver operating characteristics (ROC) curves of previous scoring systems in patients with soft CTO (left) and hard CTO (right).
Independent predictors of 30 min GW crossing CTO.
|
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| |
| Blunt entry | 0.444 | 0.216–0.913 | 0.027 | 0.081 | 0.012–0.563 | 0.011 | … | … | … |
| Failed attempt | 0.203 | 0.077–0.536 | 0.001 | … | … | … | 0.215 | 0.070–0.664 | 0.008 |
| Distal reference diameter | … | … | … | … | 4.748 | 1.698–13.275 | 0.003 | ||
| Proximal side branch | 0.352 | 0.166–0.748 | 0.007 | … | … | … | 0.250 | 0.110–0.571 | 0.001 |
| Bending > 45° | 0.232 | 0.100–0.536 | 0.001 | … | … | … | 0.066 | 0.020–0.218 | <0.001 |
| Calcium ≥ 50% CSA | 0.303 | 0.149–0.616 | 0.001 | … | … | … | 0.325 | 0.147–0.717 | 0.005 |
Data were analyzed using a Cox regression model.
Distal reference diameter was divided into ≤2.5 and >2.5 mm. CTO, chronic total occlusion; HR, hazard ratio; CI, confidence interval; CSA, cross-sectional area.
Figure 5Relationship between HCTO score and GW crossing within 30 min.